Literature DB >> 19109875

Melatonin protects liver from intestine ischemia reperfusion injury in rats.

Jian-Yi Li1, Hong-Zhuan Yin, Xi Gu, Yong Zhou, Wen-Hai Zhang, Yi-Min Qin.   

Abstract

AIM: To investigate the protective effect of melatonin on liver after intestinal ischemia-reperfusion injury in rats.
METHODS: One hundred and fifty male Wistar rats, weighing 190-210 g, aged 7 wk, were randomly divided into melatonin exposure group, alcohol solvent control group and normal saline control group. Rats in the melatonin exposure group received intraperitoneal (IP) melatonin (20 mg/kg) 30 min before intestinal ischemia-reperfusion (IR), rats in the alcohol solvent control group received the same concentration and volume of alcohol, and rats in the normal saline control group received the same volume of normal saline. Serum samples were collected from each group 0.5, 1, 6, 12, and 24 h after intestinal IR. Levels of serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) were measured with an auto-biochemical analyzer. Serum TNF-alpha was tested by enzyme-linked immunosorbent assay (ELISA). Malondialdehyde (MDA) in liver was detected by colorimetric assay. Pathological changes in liver and immunohistochemical straining of ICAM-1 were observed under an optical microscope.
RESULTS: The levels of ALT measured at various time points after intestinal IR in the melatonin exposure group were significantly lower than those in the other two control groups (P < 0.05). The serum AST levels 12 and 24 h after intestinal IR and the ICAM-1 levels (%) 6, 12 and 24 h after intestinal IR in the melatonin exposure group were also significantly lower than those in the other two control groups (P < 0.05).
CONCLUSION: Exotic melatonin can inhibit the activity of ALT, AST and TNF-alpha, decrease the accumulation of MDA, and depress the expression of ICAM-1 in liver after intestinal IR injury, thus improving the liver function.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19109875      PMCID: PMC2778125          DOI: 10.3748/wjg.14.7392

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  30 in total

1.  Nutrition and quality of life following small intestinal transplantation.

Authors:  Stephen J D O'Keefe; Maureen Emerling; Darlene Koritsky; Dolly Martin; June Stamos; Hossam Kandil; Laura Matarese; Geoffrey Bond; Kareem Abu-Elmagd
Journal:  Am J Gastroenterol       Date:  2007-03-22       Impact factor: 10.864

2.  Preclinical evaluation of pharmacokinetics and safety of melatonin in propylene glycol for intravenous administration.

Authors:  Raymond Tak Fai Cheung; George L Tipoe; Sidney Tam; Edmond Shiu Kwan Ma; Liang Yu Zou; Pui Shan Chan
Journal:  J Pineal Res       Date:  2006-11       Impact factor: 13.007

3.  Does anti-oxidant prophylaxis with melatonin prevent adverse outcomes related to increased oxidative stress caused by laparoscopy in experimental rat model?

Authors:  Ali Cay; Mustafa Imamoğlu; Mesut A Unsal; Sevim Aydin; Ahmet Alver; Ahmet Akyol; Haluk Sarihan
Journal:  J Surg Res       Date:  2006-03-29       Impact factor: 2.192

4.  Delivery of antioxidative enzyme genes protects against ischemia/reperfusion-induced liver injury in mice.

Authors:  Song-Qing He; Yan-Hong Zhang; Senthil K Venugopal; Christopher W Dicus; Richard V Perez; Rajen Ramsamooj; Michael H Nantz; Mark A Zern; Jian Wu
Journal:  Liver Transpl       Date:  2006-12       Impact factor: 5.799

5.  Apoptosis and cardiopulmonary bypass.

Authors:  Miljenko Kovacević; Ognjen Simić; Nives Jonjić; Sanja Stifter
Journal:  J Card Surg       Date:  2007 Mar-Apr       Impact factor: 1.620

6.  Melatonin abates liver ischemia/reperfusion injury by improving the balance between nitric oxide and endothelin.

Authors:  Wen-Hai Zhang; Jian-Yi Li; Yong Zhou
Journal:  Hepatobiliary Pancreat Dis Int       Date:  2006-11

7.  Melatonin reduces mortality and oxidatively mediated hepatic and renal damage due to diquat treatment.

Authors:  Jingming Xu; Shichun Sun; Wei Wei; Jianmin Fu; Wenbo Qi; Lucien C Manchester; Dun-Xian Tan; Russel J Reiter
Journal:  J Pineal Res       Date:  2007-03       Impact factor: 13.007

8.  Protective role of melatonin and coenzyme Q10 in ochratoxin A toxicity in rat liver and kidney.

Authors:  Emine Sutken; Erinc Aral; Filiz Ozdemir; Sema Uslu; Ozkan Alatas; Omer Colak
Journal:  Int J Toxicol       Date:  2007 Jan-Feb       Impact factor: 2.032

9.  Protective effects of antioxidant medications on limb ischemia reperfusion injury.

Authors:  Cengiz Bolcal; Vedat Yildirim; Suat Doganci; Murat Sargin; Ahmet Aydin; Ayse Eken; Ertugrul Ozal; Erkan Kuralay; Ufuk Demirkilic; Harun Tatar
Journal:  J Surg Res       Date:  2007-03-08       Impact factor: 2.192

10.  CXC-chemokine regulation and neutrophil trafficking in hepatic ischemia-reperfusion injury in P-selectin/ICAM-1 deficient mice.

Authors:  Keith M Monson; Shadi Dowlatshahi; Elahé T Crockett
Journal:  J Inflamm (Lond)       Date:  2007-05-24       Impact factor: 4.981

View more
  4 in total

1.  Radiation protection following nuclear power accidents: a survey of putative mechanisms involved in the radioprotective actions of taurine during and after radiation exposure.

Authors:  Olav Albert Christophersen
Journal:  Microb Ecol Health Dis       Date:  2012-02-01

Review 2.  Hepatoprotective actions of melatonin: possible mediation by melatonin receptors.

Authors:  Alexander M Mathes
Journal:  World J Gastroenterol       Date:  2010-12-28       Impact factor: 5.742

3.  Sulforaphane protects liver injury induced by intestinal ischemia reperfusion through Nrf2-ARE pathway.

Authors:  Hai-Dong Zhao; Feng Zhang; Gang Shen; Yu-Bing Li; Ying-Hua Li; Hui-Rong Jing; Ling-Fei Ma; Ji-Hong Yao; Xiao-Feng Tian
Journal:  World J Gastroenterol       Date:  2010-06-28       Impact factor: 5.742

4.  The beneficial effect of melatonin in brain endothelial cells against oxygen-glucose deprivation followed by reperfusion-induced injury.

Authors:  Juhyun Song; So Mang Kang; Won Taek Lee; Kyung Ah Park; Kyoung Min Lee; Jong Eun Lee
Journal:  Oxid Med Cell Longev       Date:  2014-07-14       Impact factor: 6.543

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.